Carolyn Taylor

Letters after your name

Clinical Research Fellow and Honorary Consultant Oncologist

Carolyn Taylor is a consultant clinical oncologist and researcher into the late effects of cancer treatments. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.

Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008. She now continues to research the late effects of cancer treatments and works in the clinic with childhood cancer survivors.

Recent publications

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Journal article

Kerr AJ. et al, (2022), Cancer Treat Rev, 105
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
Journal article

BRADLEY R. et al, (2021), The Lancet Oncology
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Journal article

Duane FK. et al, (2021), Radiother Oncol
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Journal article

Henson KE. et al, (2020), Int J Cancer

More publications